心力衰竭患者睡眠呼吸障礙的研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

LIU Jinghui ¹ , LIANG Shuang ¹ , WANG Jiachi ¹ ,  LIU Fangli ^1,2

1. ;
2. ;

Corresponding?author：

LIU Fangli, Email: liufangli1229@126.com

Keywords：

DOI：

10.7507/1671-6205.202403051

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： LIU Jinghui, LIANG Shuang, WANG Jiachi, LIU Fangli. 心力衰竭患者睡眠呼吸障礙的研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2025, 24(1): 58-63. doi: 10.7507/1671-6205.202403051 Copy

1.	GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392(10159): 1789-1858.
2.	Wang H, Chai K, Du M, et al. Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis. Circ Heart Fail, 2021, 14(10): e008406.
3.	Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American heart association. Circulation, 2023, 147(8): e93-e621.
4.	Danielsen R, Thorgeirsson G, Einarsson H, et al. Prevalence of heart failure in the elderly and future projections: the AGES-Reykjavík study. Scand Cardiovasc J, 2017, 51(4): 183-189.
5.	Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest, 2014, 146(5): 1387-1394.
6.	Ardelean CL, Lighezan DF, Pescariu S, et al. Sleep apnea syndrome and heart failure—mechanisms and consequences. Pneumologia, 2019, 68(2): 61-67.
7.	Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 2021, 144(3): e56-e67.
8.	Naughton MT, Kee K. Sleep apnea in heart failure: to treat or not to treat?. Respirology, 2017, 22(2): 217-229.
9.	陳宇潔, 韓芳, 錢小順, 等. 老年睡眠呼吸暫停綜合征診斷評估專家共識. 中國全科醫學, 2022, 25(11): 1283-1293.
10.	Omran H, Bitter T, Horstkotte D, et al. Characteristics and circadian distribution of cardiac arrhythmias in patients with heart failure and sleep-disordered breathing. Clin Res Cardiol, 2018, 107(10): 965-974.
11.	Dharia SM, Brown LK. Epidemiology of sleep-disordered breathing and heart failure: what drives what. Curr Heart Fail Rep, 2017, 14(5): 351-364.
12.	Wang T, Yu FC, Wei Q, et al. Sleep-disordered breathing in heart failure patients with different etiologies. Clin Cardiol, 2022, 45(7): 778-785.
13.	Arzt M, Oldenburg O, Graml A, et al. Prevalence and predictors of sleep-disordered breathing in chronic heart failure: the SchlaHF-XT registry. ESC Heart Fail, 2022, 9(6): 4100-4111.
14.	Arzt M, Woehrle H, Oldenburg O, et al. Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF registry. JACC Heart Fail, 2016, 4(2): 116-125.
15.	Lo S, Mbanze I, Orr JE, et al. The prevalence of sleep-disordered breathing and associated risk factors in patients with decompensated congestive heart failure in Mozambique. J Clin Sleep Med, 2023, 19(6): 1103-1110.
16.	Tamisier R, Bocquillon V, Treptow E, et al. Prevalence and factors contributing to daytime and nocturnal hypoxemia in chronic heart failure patients. Respiration, 2019, 97(3): 213-222.
17.	Huang B, Huang Y, Zhai M, et al. Prevalence, clinical characteristics, and predictors of sleep disordered breathing in hospitalized heart failure patients. Clin Cardiol, 2022, 45(12): 1311-1318.
18.	Pearse SG, Cowie MR. Sleep-disordered breathing in heart failure. Eur J Heart Fail, 2016, 18(4): 353-361.
19.	Javaheri S, Badr MS. Central sleep apnea: pathophysiologic classification. Sleep, 2023, 46(3): zsac113.
20.	張慧, 呂慧霞. 阻塞性睡眠呼吸暫停在心衰進展中的作用機制及其治療研究進展. 山東大學耳鼻喉眼學報, 2023, 37(6): 33-40.
21.	Parati G, Lombardi C, Castagna F, et al. Heart failure and sleep disorders. Nat Rev Cardiol, 2016, 13(7): 389-403.
22.	Taranto ML, Floras JS, Picton P, et al. Relationship of heart rate variability to sleepiness in patients with obstructive sleep apnea with and without heart failure. J Clin Sleep Med, 2014, 10(3): 271-276.
23.	Ott SR, Korostovtseva L, Schmidt M, et al. Sleep-disordered breathing: clinical features, pathophysiology and diagnosis. Swiss Med Wkly, 2020, 147: w14436.
24.	Sands SA, Owens RL. Congestive heart failure and central sleep apnea. Sleep Med Clin, 2016, 11(1): 127-142.
25.	Javaheri S, Brown LK, Abraham WT, et al. Apneas of heart failure and phenotype-guided treatments: part one: OSA. Chest, 2020, 157(2): 394-402.
26.	朱鵬力, 趙信科, 蔣虎剛, 等. 心力衰竭合并中樞型睡眠呼吸暫停綜合征的治療方案及機制研究新進展. 心血管病學進展, 2021, 42(1): 59-63.
27.	Zhang K, Ma Z, Song C, et al. Role of ion channels in chronic intermittent hypoxia-induced atrial remodeling in rats. Life Sci, 2020, 254: 117797.
28.	Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med, 1999, 131(7): 485-491.
29.	Saengsuwan J, Ungtrakul N, Saengsuwan J, et al. Preliminary validity and reliability of a Thai Berlin questionnaire in stroke patients. BMC Res Notes, 2014, 7: 348.
30.	Lauritzen E, K?rvel HA, Hom?e P. The Danish translation and validation of the Berlin questionnaire for sleep apnoea. Dan Med J, 2018, 65(9): A5502.
31.	Senaratna CV, Perret JL, Matheson MC, et al. Validity of the Berlin questionnaire in detecting obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med Rev, 2017, 36: 116-124.
32.	Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 1991, 14(6): 540-545.
33.	Johns MW. Reliability and factor analysis of the Epworth sleepiness scale. Sleep, 1992, 15(4): 376-381.
34.	彭莉莉, 李進讓, 孫建軍, 等. Epworth嗜睡量表簡體中文版信度和效度評價. 中華耳鼻咽喉頭頸外科雜志, 2011, 46(1): 6.
35.	Lok R, Zeitzer JM. Physiological correlates of the Epworth sleepiness scale reveal different dimensions of daytime sleepiness. Sleep Adv, 2021, 2(1): zpab008.
36.	Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology, 2008, 108(5): 812-821.
37.	Chiu HY, Chen PY, Chuang LP, et al. Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: a bivariate meta-analysis. Sleep Med Rev, 2017, 36: 57-70.
38.	Marti SH, Hirotsu C, Marques VP, et al. The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Respir Med, 2016, 4(9): 742-748.
39.	Hong C, Chen R, Qing S, et al. Validation of the NoSAS score for the screening of sleep-disordered breathing: a hospital-based retrospective study in China. J Clin Sleep Med, 2018, 14(2): 191-197.
40.	Herschmann S, Berger M, Haba RJ, et al. Comparison of NoSAS score with Berlin and STOP-BANG scores for sleep apnea detection in a clinical sample. Sleep Med, 2021, 79: 113-116.
41.	Koseoglu HI, Pazarli AC, Kanbay A, et al. NoSAS score predicts cardiovascular disease in patients with obstructive sleep apnea. Sleep Breath, 2024, 28(1): 87-93.
42.	Rundo JV, Downey R 3rd. Polysomnography. Handb Clin Neurol, 2019, 160: 381-392.
43.	Zhang X, Song Z, Ye J, et al. Polysomnographic and neuropsychological characteristics of rapid eye movement sleep behavior disorder patients. Brain Behav, 2019, 9(3): e01220.
44.	Hertenstein E, Gabryelska A, Spiegelhalder K, et al. Reference data for polysomnography-measured and subjective sleep in healthy adults. J Clin Sleep Med, 2018, 14(4): 523-532.
45.	Kreutz C, Müller J, Schmidt ME, et al. Comparison of subjectively and objectively assessed sleep problems in breast cancer patients starting neoadjuvant chemotherapy. Support Care Cancer, 2021, 29(2): 1015-1023.
46.	楊璇, 喬雨晨, 趙潔, 等. 認知障礙患者睡眠障礙評估工具的應用進展. 中華護理雜志, 2020, 55(12): 1884-1889.
47.	Cabanel N, Speier C, Müller MJ, et al. Actigraphic, but not subjective, sleep measures are associatedwith cognitive impairment in memory clinic patients. Psychogeriatrics, 2020, 20(2): 133-139.
48.	Patterson MR, Nunes AAS, Gerstel D, et al. 40 years of actigraphy in sleep medicine and current state of the art algorithms. NPJ Digit Med, 2023, 6(1): 51.
49.	Smith MT, Mccrae CS, Cheung J, et al. Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med, 2018, 14(7): 1231-1237.
50.	Hernandez AV, Jeon A, Denegri GJ, et al. Use of adaptive servo ventilation therapy as treatment of sleep-disordered breathing and heart failure: a systematic review and meta-analysis. Sleep Breath, 2020, 24(1): 49-63.
51.	Alemohammad ZB, Sadeghniiat HK, Fazlipanah MMP, et al. The effects of CPAP therapy on metabolic profile and subjective sleep parameters in patients with OSA: a prospective trial study. Sleep Sci, 2022, 15(2): 196-200.
52.	張文珺, 劉永銘. 睡眠呼吸障礙對射血分數保留性心力衰竭影響及治療的研究進展. 中國臨床研究, 2022, 35(04): 552-555.
53.	Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2022, 79(17): e263-e421.
54.	Han YC, Shen ZJ, Zhang SY, et al. Efficacy of adaptive servo-ventilation and continuous positive airway pressure treatment in chronic heart failure with sleep-disordered breathing: a systematic review and meta-analysis. Heart Fail Rev, 2021, 26(3): 521-529.
55.	Ponce S, Pastor E, Orosa B, et al. The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial. Eur Respir J, 2019, 54(2): 1900518.
56.	Randerath W, Deleanu O, Schiza S, et al. Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options. Eur Respir Rev, 2019, 28(153): 190084.
57.	郭舒雯, 許鑫. 適應性支持通氣治療慢性心力衰竭合并睡眠呼吸障礙疾病42例. 心理月刊, 2019, 14(13): 179.
58.	Wang J, Covassin N, Dai T, et al. Therapeutic value of treating central sleep apnea by adaptive servo-ventilation in patients with heart failure: a systematic review and meta-analysis. Heart Lung, 2021, 50(2): 344-351.
59.	朱鵬力, 趙信科, 蔣虎剛, 等. 膈神經刺激在中樞性和阻塞性睡眠呼吸暫停綜合征治療中的應用研究進展. 中國實用內科雜志, 2021, 41(12): 1069-1072+1077.
60.	Costanzo MR, Ponikowski P, Coats A, et al. Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure. Eur J Heart Fail, 2018, 20(12): 1746-1754.
61.	Fudim M, Spector AR, Costanzo MR, et al. Phrenic nerve stimulation for the treatment of central sleep apnea: a pooled cohort analysis. J Clin Sleep Med, 2019, 15(12): 1747-1755.
62.	Fox H, Oldenburg O, Javaheri S, et al. Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea. Sleep, 2019, 42(11): zsz158.
63.	Abraham WT, Jagielski D, Oldenburg O, et al. Phrenic nerve stimulation for the treatment of central sleep apnea. JACC Heart Fail, 2015, 3(5): 360-369.
64.	黃曉蕓, 莊振中, 江意春, 等. 體外膈肌起搏器在慢性心衰患者治療中的作用. 中國醫學物理學雜志, 2017, 34(01): 84-88.
65.	Randerath W, Verbraecken J, Andreas S, et al. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J, 2017, 49(1): 1600959.
66.	Yoshihisa A, Takeishi Y. Heart failure and sleep disordered breathing. Fukushima J Med Sci, 2017, 63(2): 32-38.
67.	席紫明. 茶堿對慢性心力衰竭合并睡眠呼吸障礙患者睡眠狀態的影響觀察. 世界睡眠醫學雜志, 2018, 5(7): 843-845.
68.	李勝男, 謝亮, 童嘉毅. 阻塞性睡眠呼吸暫停的藥物治療研究進展. 心血管病學進展, 2023, 44(8): 748-751,756.
69.	Eskandari D, Zou D, Grote L, et al. Acetazolamide reduces blood pressure and sleep-disordered breathing in patients with hypertension and obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med, 2018, 14(3): 309-317.
70.	Nakao YM, Ueshima K, Yasuno S, et al. Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study. Heart Vessels, 2016, 31(2): 165-172.

1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392(10159): 1789-1858.
2. Wang H, Chai K, Du M, et al. Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis. Circ Heart Fail, 2021, 14(10): e008406.
3. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American heart association. Circulation, 2023, 147(8): e93-e621.
4. Danielsen R, Thorgeirsson G, Einarsson H, et al. Prevalence of heart failure in the elderly and future projections: the AGES-Reykjavík study. Scand Cardiovasc J, 2017, 51(4): 183-189.
5. Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest, 2014, 146(5): 1387-1394.
6. Ardelean CL, Lighezan DF, Pescariu S, et al. Sleep apnea syndrome and heart failure—mechanisms and consequences. Pneumologia, 2019, 68(2): 61-67.
7. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 2021, 144(3): e56-e67.
8. Naughton MT, Kee K. Sleep apnea in heart failure: to treat or not to treat?. Respirology, 2017, 22(2): 217-229.
9. 陳宇潔, 韓芳, 錢小順, 等. 老年睡眠呼吸暫停綜合征診斷評估專家共識. 中國全科醫學, 2022, 25(11): 1283-1293.
10. Omran H, Bitter T, Horstkotte D, et al. Characteristics and circadian distribution of cardiac arrhythmias in patients with heart failure and sleep-disordered breathing. Clin Res Cardiol, 2018, 107(10): 965-974.
11. Dharia SM, Brown LK. Epidemiology of sleep-disordered breathing and heart failure: what drives what. Curr Heart Fail Rep, 2017, 14(5): 351-364.
12. Wang T, Yu FC, Wei Q, et al. Sleep-disordered breathing in heart failure patients with different etiologies. Clin Cardiol, 2022, 45(7): 778-785.
13. Arzt M, Oldenburg O, Graml A, et al. Prevalence and predictors of sleep-disordered breathing in chronic heart failure: the SchlaHF-XT registry. ESC Heart Fail, 2022, 9(6): 4100-4111.
14. Arzt M, Woehrle H, Oldenburg O, et al. Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF registry. JACC Heart Fail, 2016, 4(2): 116-125.
15. Lo S, Mbanze I, Orr JE, et al. The prevalence of sleep-disordered breathing and associated risk factors in patients with decompensated congestive heart failure in Mozambique. J Clin Sleep Med, 2023, 19(6): 1103-1110.
16. Tamisier R, Bocquillon V, Treptow E, et al. Prevalence and factors contributing to daytime and nocturnal hypoxemia in chronic heart failure patients. Respiration, 2019, 97(3): 213-222.
17. Huang B, Huang Y, Zhai M, et al. Prevalence, clinical characteristics, and predictors of sleep disordered breathing in hospitalized heart failure patients. Clin Cardiol, 2022, 45(12): 1311-1318.
18. Pearse SG, Cowie MR. Sleep-disordered breathing in heart failure. Eur J Heart Fail, 2016, 18(4): 353-361.
19. Javaheri S, Badr MS. Central sleep apnea: pathophysiologic classification. Sleep, 2023, 46(3): zsac113.
20. 張慧, 呂慧霞. 阻塞性睡眠呼吸暫停在心衰進展中的作用機制及其治療研究進展. 山東大學耳鼻喉眼學報, 2023, 37(6): 33-40.
21. Parati G, Lombardi C, Castagna F, et al. Heart failure and sleep disorders. Nat Rev Cardiol, 2016, 13(7): 389-403.
22. Taranto ML, Floras JS, Picton P, et al. Relationship of heart rate variability to sleepiness in patients with obstructive sleep apnea with and without heart failure. J Clin Sleep Med, 2014, 10(3): 271-276.
23. Ott SR, Korostovtseva L, Schmidt M, et al. Sleep-disordered breathing: clinical features, pathophysiology and diagnosis. Swiss Med Wkly, 2020, 147: w14436.
24. Sands SA, Owens RL. Congestive heart failure and central sleep apnea. Sleep Med Clin, 2016, 11(1): 127-142.
25. Javaheri S, Brown LK, Abraham WT, et al. Apneas of heart failure and phenotype-guided treatments: part one: OSA. Chest, 2020, 157(2): 394-402.
26. 朱鵬力, 趙信科, 蔣虎剛, 等. 心力衰竭合并中樞型睡眠呼吸暫停綜合征的治療方案及機制研究新進展. 心血管病學進展, 2021, 42(1): 59-63.
27. Zhang K, Ma Z, Song C, et al. Role of ion channels in chronic intermittent hypoxia-induced atrial remodeling in rats. Life Sci, 2020, 254: 117797.
28. Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med, 1999, 131(7): 485-491.
29. Saengsuwan J, Ungtrakul N, Saengsuwan J, et al. Preliminary validity and reliability of a Thai Berlin questionnaire in stroke patients. BMC Res Notes, 2014, 7: 348.
30. Lauritzen E, K?rvel HA, Hom?e P. The Danish translation and validation of the Berlin questionnaire for sleep apnoea. Dan Med J, 2018, 65(9): A5502.
31. Senaratna CV, Perret JL, Matheson MC, et al. Validity of the Berlin questionnaire in detecting obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med Rev, 2017, 36: 116-124.
32. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 1991, 14(6): 540-545.
33. Johns MW. Reliability and factor analysis of the Epworth sleepiness scale. Sleep, 1992, 15(4): 376-381.
34. 彭莉莉, 李進讓, 孫建軍, 等. Epworth嗜睡量表簡體中文版信度和效度評價. 中華耳鼻咽喉頭頸外科雜志, 2011, 46(1): 6.
35. Lok R, Zeitzer JM. Physiological correlates of the Epworth sleepiness scale reveal different dimensions of daytime sleepiness. Sleep Adv, 2021, 2(1): zpab008.
36. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology, 2008, 108(5): 812-821.
37. Chiu HY, Chen PY, Chuang LP, et al. Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: a bivariate meta-analysis. Sleep Med Rev, 2017, 36: 57-70.
38. Marti SH, Hirotsu C, Marques VP, et al. The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Respir Med, 2016, 4(9): 742-748.
39. Hong C, Chen R, Qing S, et al. Validation of the NoSAS score for the screening of sleep-disordered breathing: a hospital-based retrospective study in China. J Clin Sleep Med, 2018, 14(2): 191-197.
40. Herschmann S, Berger M, Haba RJ, et al. Comparison of NoSAS score with Berlin and STOP-BANG scores for sleep apnea detection in a clinical sample. Sleep Med, 2021, 79: 113-116.
41. Koseoglu HI, Pazarli AC, Kanbay A, et al. NoSAS score predicts cardiovascular disease in patients with obstructive sleep apnea. Sleep Breath, 2024, 28(1): 87-93.
42. Rundo JV, Downey R 3rd. Polysomnography. Handb Clin Neurol, 2019, 160: 381-392.
43. Zhang X, Song Z, Ye J, et al. Polysomnographic and neuropsychological characteristics of rapid eye movement sleep behavior disorder patients. Brain Behav, 2019, 9(3): e01220.
44. Hertenstein E, Gabryelska A, Spiegelhalder K, et al. Reference data for polysomnography-measured and subjective sleep in healthy adults. J Clin Sleep Med, 2018, 14(4): 523-532.
45. Kreutz C, Müller J, Schmidt ME, et al. Comparison of subjectively and objectively assessed sleep problems in breast cancer patients starting neoadjuvant chemotherapy. Support Care Cancer, 2021, 29(2): 1015-1023.
46. 楊璇, 喬雨晨, 趙潔, 等. 認知障礙患者睡眠障礙評估工具的應用進展. 中華護理雜志, 2020, 55(12): 1884-1889.
47. Cabanel N, Speier C, Müller MJ, et al. Actigraphic, but not subjective, sleep measures are associatedwith cognitive impairment in memory clinic patients. Psychogeriatrics, 2020, 20(2): 133-139.
48. Patterson MR, Nunes AAS, Gerstel D, et al. 40 years of actigraphy in sleep medicine and current state of the art algorithms. NPJ Digit Med, 2023, 6(1): 51.
49. Smith MT, Mccrae CS, Cheung J, et al. Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med, 2018, 14(7): 1231-1237.
50. Hernandez AV, Jeon A, Denegri GJ, et al. Use of adaptive servo ventilation therapy as treatment of sleep-disordered breathing and heart failure: a systematic review and meta-analysis. Sleep Breath, 2020, 24(1): 49-63.
51. Alemohammad ZB, Sadeghniiat HK, Fazlipanah MMP, et al. The effects of CPAP therapy on metabolic profile and subjective sleep parameters in patients with OSA: a prospective trial study. Sleep Sci, 2022, 15(2): 196-200.
52. 張文珺, 劉永銘. 睡眠呼吸障礙對射血分數保留性心力衰竭影響及治療的研究進展. 中國臨床研究, 2022, 35(04): 552-555.
53. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2022, 79(17): e263-e421.
54. Han YC, Shen ZJ, Zhang SY, et al. Efficacy of adaptive servo-ventilation and continuous positive airway pressure treatment in chronic heart failure with sleep-disordered breathing: a systematic review and meta-analysis. Heart Fail Rev, 2021, 26(3): 521-529.
55. Ponce S, Pastor E, Orosa B, et al. The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial. Eur Respir J, 2019, 54(2): 1900518.
56. Randerath W, Deleanu O, Schiza S, et al. Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options. Eur Respir Rev, 2019, 28(153): 190084.
57. 郭舒雯, 許鑫. 適應性支持通氣治療慢性心力衰竭合并睡眠呼吸障礙疾病42例. 心理月刊, 2019, 14(13): 179.
58. Wang J, Covassin N, Dai T, et al. Therapeutic value of treating central sleep apnea by adaptive servo-ventilation in patients with heart failure: a systematic review and meta-analysis. Heart Lung, 2021, 50(2): 344-351.
59. 朱鵬力, 趙信科, 蔣虎剛, 等. 膈神經刺激在中樞性和阻塞性睡眠呼吸暫停綜合征治療中的應用研究進展. 中國實用內科雜志, 2021, 41(12): 1069-1072+1077.
60. Costanzo MR, Ponikowski P, Coats A, et al. Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure. Eur J Heart Fail, 2018, 20(12): 1746-1754.
61. Fudim M, Spector AR, Costanzo MR, et al. Phrenic nerve stimulation for the treatment of central sleep apnea: a pooled cohort analysis. J Clin Sleep Med, 2019, 15(12): 1747-1755.
62. Fox H, Oldenburg O, Javaheri S, et al. Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea. Sleep, 2019, 42(11): zsz158.
63. Abraham WT, Jagielski D, Oldenburg O, et al. Phrenic nerve stimulation for the treatment of central sleep apnea. JACC Heart Fail, 2015, 3(5): 360-369.
64. 黃曉蕓, 莊振中, 江意春, 等. 體外膈肌起搏器在慢性心衰患者治療中的作用. 中國醫學物理學雜志, 2017, 34(01): 84-88.
65. Randerath W, Verbraecken J, Andreas S, et al. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J, 2017, 49(1): 1600959.
66. Yoshihisa A, Takeishi Y. Heart failure and sleep disordered breathing. Fukushima J Med Sci, 2017, 63(2): 32-38.
67. 席紫明. 茶堿對慢性心力衰竭合并睡眠呼吸障礙患者睡眠狀態的影響觀察. 世界睡眠醫學雜志, 2018, 5(7): 843-845.
68. 李勝男, 謝亮, 童嘉毅. 阻塞性睡眠呼吸暫停的藥物治療研究進展. 心血管病學進展, 2023, 44(8): 748-751,756.
69. Eskandari D, Zou D, Grote L, et al. Acetazolamide reduces blood pressure and sleep-disordered breathing in patients with hypertension and obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med, 2018, 14(3): 309-317.
70. Nakao YM, Ueshima K, Yasuno S, et al. Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study. Heart Vessels, 2016, 31(2): 165-172.

Previous Article
體外膜氧合成功救治惠普爾養障體重癥肺炎并多器官功能障礙綜合征一例
Next Article
阻塞性睡眠呼吸暫停損害心臟的分子機制研究進展

Chinese Journal of Respiratory and Critical Care Medicine

心力衰竭患者睡眠呼吸障礙的研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content